InsiderTrades

Form 4 for NVNO enVVeno Medical Corp

Accepted 2021-11-18 00:00:00 ET · period of report 2021-11-16 · accession 0001493152-21-029234 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-18 2021-11-16 NVNO Shrivastava Sanjay Dir M - OptEx — +388 2,888 +16% —
D 2021-11-18 2021-11-16 NVNO Shrivastava Sanjay Dir M - OptEx $0.00 -388 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-16 M A 388 — 2,888 D — — (F2) The RSUs were issued to the Reporting person on November 27, 2018, in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the "Plan"), subject to vesting and settlement as described in the person's Form 4, as filed on November 6, 2019. The vesting and settlement of 388 RSUs occurred on November 16, 2021.
2 Derivative Restricted Stock Units 2021-11-16 M D 388 $0.00 0 D — · — to — 388 Common Stock (F1) Each restricted stock unit ("RSU") converts into one share of common stock of enVVeno Medical Corporation. (F2) The RSUs were issued to the Reporting person on November 27, 2018, in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the "Plan"), subject to vesting and settlement as described in the person's Form 4, as filed on November 6, 2019. The vesting and settlement of 388 RSUs occurred on November 16, 2021.